| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Salidroside | Aplastic Anemia | 1 | PM | 37439434 | 📋 | Salidroside affects the Th17/Treg cell balance in aplastic anemia via the STAT3/HIF-1α/RORγt pathway |
| Salidroside | Atherosclerosis | 1 | PM | 34504429 | 📋 | Salidroside Ameliorated Intermittent Hypoxia-Aggravated Endothelial Barrier Disruption and Atherosclerosis via the cAMP/PKA/RhoA Signaling Pathway |
| Salidroside | Atherosclerosis | 3 | PM | 33732368 | 📋 | Salidroside and isorhamnetin attenuate urotensin II-induced inflammatory response in vivo and in vitro: Involvement in regulating the RhoA/ROCK II pathway |
| Salidroside | Atherosclerosis | 2 | PM | 33341055 | 📋 | Salidroside simultaneously reduces de novo lipogenesis and cholesterol biosynthesis to attenuate atherosclerosis in mice |
| Salidroside | Atherosclerosis | 12 | PM | 32685103 | 📋 | Salidroside-Mediated Autophagic Targeting of Active Src and Caveolin-1 Suppresses Low-Density Lipoprotein Transcytosis across Endothelial Cells |
| Salidroside | Atherosclerosis | 11 | PM | 32076940 | 📋 | Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis |
| Salidroside | Atherosclerosis | 10 | PM | 31656544 | 📋 | Salidroside prevents tumor necrosis factor-α-induced vascular inflammation by blocking mitogen-activated protein kinase and NF-κB signaling activation |
| Salidroside | Atherosclerosis | 9 | PM | 31146723 | 📋 | Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway |
| Salidroside | Atherosclerosis | 8 | PM | 29289557 | 📋 | Salidroside attenuates endothelial cellular senescence via decreasing the expression of inflammatory cytokines and increasing the expression of SIRT3 |
| Salidroside | Atherosclerosis | 7 | PM | 29115447 | 📋 | Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model |
| Salidroside | Atherosclerosis | 5 | PM | 29017559 | 📋 | Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways |
| Salidroside | Atherosclerosis | 6 | PM | 26187353 | 📋 | Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway |
| Salidroside | Atherosclerosis | 4 | PM | 23093983 | 📋 | Salidroside decreases atherosclerotic plaque formation in low-density lipoprotein receptor-deficient mice |
| Salidroside | Atrial Fibrillation | 1 | PM | 37920527 | 📋 | Salidroside attenuates atrial fibrosis and atrial fibrillation vulnerability induced by angiotensin-II through inhibition of LOXL2-TGF-β1-Smad2/3 pathway |
| Salidroside | Blood-Brain Barrier Permeability | 2 | PM | 38417575 | 📋 | Salidroside promotes pro-angiogenesis and repair of blood brain barrier via Notch/ITGB1 signal path in CSVD Model |
| Salidroside | Blood-Brain Barrier Permeability | 1 | PM | 23339921 | 📋 | Effects of salidroside pretreatment on expression of tumor necrosis factor-alpha and permeability of blood brain barrier in rat model of focal cerebralischemia-reperfusion injury |
| Salidroside | Cardiac Arrhythmia | 1 | PM | 32946036 | 📋 | Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway |
| Salidroside | Cardiac Hypertrophy | 2 | PM | 36512326 | 📋 | Salidroside ameliorates pathological cardiac hypertrophy via TLR4-TAK1-dependent signaling |
| Salidroside | Cardiac Hypertrophy | 1 | PM | 35479323 | 📋 | Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α |
| Salidroside | Cardiotoxicity | 1 | PM | 35180677 | 📋 | Salidroside inhibits doxorubicin-induced cardiomyopathy by modulating a ferroptosis-dependent pathway |
| Salidroside | Cardiotoxicity | 2 | PM | 32671648 | 📋 | Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway |
| Salidroside | Cardiotoxicity | 4 | PM | 24072175 | 📋 | Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis |
| Salidroside | Cardiotoxicity | 3 | PM | 22770377 | 📋 | Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer |
| Salidroside | Cardiotoxicity | 5 | PM | 21563965 | 📋 | Salidroside protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via PI3K-Akt dependent pathway |
| Salidroside | Cardiovascular Disease | 1 | PM | 33991395 | 📋 | The therapeutic effects and mechanisms of salidroside on cardiovascular and metabolic diseases: An updated review |
| Salidroside | Cardiovascular Disease | 2 | PM | 33062029 | 📋 | Antioxidant Effects of Salidroside in the Cardiovascular System |
| Salidroside | Cerebral Hypoperfusion | 1 | PM | 25858674 | 📋 | Salidroside prevents cognitive impairment induced by chronic cerebral hypoperfusion in rats |
| Salidroside | Cerebral Hypoxia | 1 | PM | 29434685 | 📋 | Salidroside attenuates hypoxia/reoxygenation-induced human brain vascular smooth muscle cell injury by activating the SIRT1/FOXO3α pathway |
| Salidroside | Cerebral Ischemia | 7 | PM | 38643543 | 📋 | Salidroside promotes angiogenesis after cerebral ischemia in mice through Shh signaling pathway |
| Salidroside | Cerebral Ischemia | 1 | PM | 34181207 | 📋 | Protective Effect of Salidroside on Mitochondrial Disturbances via Reducing Mitophagy and Preserving Mitochondrial Morphology in OGD-induced Neuronal Injury |
| Salidroside | Cerebral Ischemia | 2 | PM | 33389472 | 📋 | Salidroside Inhibits Reactive Astrogliosis and Glial Scar Formation in Late Cerebral Ischemia via the Akt/GSK-3β Pathway |
| Salidroside | Cerebral Ischemia | 6 | PM | 30223020 | 📋 | 2-(4-Methoxyphenyl)ethyl-2-Acetamido-2-deoxy-β-d-pyranoside (A Salidroside Analog) Confers Neuroprotection with a Wide Therapeutic Window by Regulating Local Glucose Metabolism in a Rat Model of Cerebral Ischemic Injury |
| Salidroside | Cerebral Ischemia | 5 | PM | 28478514 | 📋 | Salidroside Inhibits Inflammation Through PI3K/Akt/HIF Signaling After Focal Cerebral Ischemia in Rats |
| Salidroside | Cerebral Ischemia | 4 | PM | 26563497 | 📋 | Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia |
| Salidroside | Cerebral Ischemia | 3 | PM | 22095090 | 📋 | Neuroprotective effects of Salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and H2O2-induced neurotoxicity in vitro |
| Salidroside | Cerebral Ischemia-Reperfusion | 6 | PM | 36472035 | 📋 | [Protection of salidroside on endothelial cell barrier in cerebral ischemia-reperfusion model rats] |
| Salidroside | Cerebral Ischemia-Reperfusion | 5 | PM | 36374318 | 📋 | Salidroside attenuates cerebral ischemia/reperfusion injury by regulating TSC2-induced autophagy |
| Salidroside | Cerebral Ischemia-Reperfusion | 4 | PM | 35976554 | 📋 | Salidroside inhibited cerebral ischemia/reperfusion-induced oxidative stress and apoptosis via Nrf2/Trx1 signaling pathway |
| Salidroside | Cerebral Ischemia-Reperfusion | 1 | PM | 35543160 | 📋 | Salidroside Ameliorates Ischemia-Induced Neuronal Injury through AMPK Dependent and Independent Pathways to Maintain Mitochondrial Quality Control |
| Salidroside | Cerebral Ischemia-Reperfusion | 3 | PM | 34988203 | 📋 | Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB signaling pathway |
| Salidroside | Cerebral Ischemia-Reperfusion | 2 | PM | 33747287 | 📋 | Salidroside regulates imbalance of Th17/Treg and promotes ischemic tolerance by targeting STAT-3 in cerebral ischemia-reperfusion injury |
| Salidroside | Cerebral Ischemia-Reperfusion | 11 | PM | 33240590 | 📋 | Effects of rhodioloside on the neurological functions of rats with total cerebral ischemia/reperfusion and cone neuron injury in the hippocampal CA1 region |
| Salidroside | Cerebral Ischemia-Reperfusion | 8 | PM | 31920641 | 📋 | Neuroprotective Effects of Salidroside on Cerebral Ischemia/Reperfusion-Induced Behavioral Impairment Involves the Dopaminergic System |
| Salidroside | Cerebral Ischemia-Reperfusion | 10 | PM | 29434685 | 📋 | Salidroside attenuates hypoxia/reoxygenation-induced human brain vascular smooth muscle cell injury by activating the SIRT1/FOXO3α pathway |
| Salidroside | Cerebral Ischemia-Reperfusion | 9 | PM | 25911293 | 📋 | Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window |
| Salidroside | Cerebral Ischemia-Reperfusion | 7 | PM | 23339921 | 📋 | Effects of salidroside pretreatment on expression of tumor necrosis factor-alpha and permeability of blood brain barrier in rat model of focal cerebralischemia-reperfusion injury |
| Salidroside | Coronary Artery Disease | 1 | PM | 37308900 | 📋 | Mechanism of salidroside against coronary artery disease by network pharmacology analysis |
| Salidroside | Diabetic Cardiomyopathy | 2 | PM | 34467560 | 📋 | Salidroside attenuates cardiac dysfunction in a rat model of diabetes |
| Salidroside | Diabetic Cardiomyopathy | 1 | PM | 34056772 | 📋 | Salidroside protects cardiac function in mice with diabetic cardiomyopathy via activation of mitochondrial biogenesis and SIRT3 |
| Salidroside | Diabetic Cardiomyopathy | 3 | PM | 33422954 | 📋 | Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model |
| Salidroside | Diabetic Vasculopathy | 1 | PM | 28803422 | 📋 | Salidroside improved cerebrovascular vasodilation in streptozotocin-induced diabetic rats through restoring the function of BKCa channel in smooth muscle cells |
| Salidroside | Endothelial Dysfunction | 4 | PM | 37308414 | 📋 | [Protective effects of salidroside on vascular endothelial cells in rats with frostbite after chronic hypoxia] |
| Salidroside | Endothelial Dysfunction | 3 | PM | 36472035 | 📋 | [Protection of salidroside on endothelial cell barrier in cerebral ischemia-reperfusion model rats] |
| Salidroside | Endothelial Dysfunction | 2 | PM | 34269814 | 📋 | Salidroside Prevents Hypoxia-Induced Human Retinal Microvascular Endothelial Cell Damage Via miR-138/ROBO4 Axis |
| Salidroside | Endothelial Dysfunction | 1 | PM | 34011327 | 📋 | Salidroside protects endothelial cells against LPS-induced inflammatory injury by inhibiting NLRP3 and enhancing autophagy |
| Salidroside | Endothelial Dysfunction | 12 | PM | 32945356 | 📋 | Salidroside downregulates microRNA‑133a and inhibits endothelial cell apoptosis induced by oxidized low‑density lipoprotein |
| Salidroside | Endothelial Dysfunction | 10 | PM | 31747547 | 📋 | Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs |
| Salidroside | Endothelial Dysfunction | 11 | PM | 31701353 | 📋 | Salidroside Restores an Anti-inflammatory Endothelial Phenotype by Selectively Inhibiting Endothelial Complement After Oxidative Stress |
| Salidroside | Endothelial Dysfunction | 9 | PM | 29289557 | 📋 | Salidroside attenuates endothelial cellular senescence via decreasing the expression of inflammatory cytokines and increasing the expression of SIRT3 |
| Salidroside | Endothelial Dysfunction | 8 | PM | 29115447 | 📋 | Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model |
| Salidroside | Endothelial Dysfunction | 7 | PM | 27848074 | 📋 | Induction of autophagy by salidroside through the AMPK-mTOR pathway protects vascular endothelial cells from oxidative stress-induced apoptosis |
| Salidroside | Endothelial Dysfunction | 6 | PM | 26187353 | 📋 | Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway |
| Salidroside | Endothelial Dysfunction | 5 | PM | 23589720 | 📋 | Salidroside improves homocysteine-induced endothelial dysfunction by reducing oxidative stress |
| Salidroside | Endothelial Injury | 1 | PM | 34504429 | 📋 | Salidroside Ameliorated Intermittent Hypoxia-Aggravated Endothelial Barrier Disruption and Atherosclerosis via the cAMP/PKA/RhoA Signaling Pathway |
| Salidroside | Endothelial Injury | 6 | PM | 31146723 | 📋 | Salidroside protects against ox-LDL-induced endothelial injury by enhancing autophagy mediated by SIRT1-FoxO1 pathway |
| Salidroside | Endothelial Injury | 2 | PM | 30942428 | 📋 | Salidroside attenuates oxidized low‑density lipoprotein‑induced endothelial cell injury via promotion of the AMPK/SIRT1 pathway |
| Salidroside | Endothelial Injury | 5 | PM | 27809414 | 📋 | Salidroside protects against homocysteine-induced injury in human umbilical vein endothelial cells via the regulation of endoplasmic reticulum stress |
| Salidroside | Endothelial Injury | 4 | PM | 27517893 | 📋 | Salidroside Suppresses HUVECs Cell Injury Induced by Oxidative Stress through Activating the Nrf2 Signaling Pathway |
| Salidroside | Endothelial Injury | 3 | PM | 23660824 | 📋 | Salidroside protects against hydrogen peroxide-induced injury in HUVECs via the regulation of REDD1 and mTOR activation |
| Salidroside | Gestational Hypertension | 1 | PM | 38641312 | 📋 | Salidroside prevents gestational hypertension-induced impairment of offspring learning and memory via Wnt/Skp2 pathway |
| Salidroside | Hepatic Ischemia-Reperfusion | 1 | PM | 35978104 | 📋 | Salidroside alleviates hepatic ischemia-reperfusion injury during liver transplant in rat through regulating TLR-4/NF-κB/NLRP3 inflammatory pathway |
| Salidroside | Hepatic Ischemia-Reperfusion | 3 | PM | 28721018 | 📋 | Salidroside pretreatment attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting the mitogen-activated protein kinase pathway in mice |
| Salidroside | Hepatic Ischemia-Reperfusion | 2 | PM | 28411054 | 📋 | Salidroside protects rat liver against ischemia/reperfusion injury by regulating the GSK-3β/Nrf2-dependent antioxidant response and mitochondrial permeability transition |
| Salidroside | Hypertension | 1 | PM | 28441970 | 📋 | Salidroside contributes to reducing blood pressure and alleviating cerebrovascular contractile activity in diabetic Goto-Kakizaki Rats by inhibition of L-type calcium channel in smooth muscle cells |
| Salidroside | Intestinal Ischemia-Reperfusion | 1 | PM | 37530723 | 📋 | Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of salidroside on intestine ischemia reperfusion |
| Salidroside | Ischemia Injury | 1 | PM | 36060000 | 📋 | Therapeutic potential and molecular mechanisms of salidroside in ischemic diseases |
| Salidroside | Ischemia-Reperfusion Injuries | 1 | PM | 36907990 | 📋 | Salidroside postconditioning attenuates ferroptosis-mediated lung ischemia-reperfusion injury by activating the Nrf2/SLC7A11 signaling axis |
| Salidroside | Ischemia-Reperfusion Injuries | 2 | PM | 32774670 | 📋 | Salidroside Ameliorates Mitochondria-Dependent Neuronal Apoptosis after Spinal Cord Ischemia-Reperfusion Injury Partially through Inhibiting Oxidative Stress and Promoting Mitophagy |
| Salidroside | Ischemic Stroke | 7 | PM | 38488455 | 📋 | Salidroside directly activates HSC70, revealing a new role for HSC70 in BDNF signalling and neurogenesis after cerebral ischemia |
| Salidroside | Ischemic Stroke | 3 | PM | 36374318 | 📋 | Salidroside attenuates cerebral ischemia/reperfusion injury by regulating TSC2-induced autophagy |
| Salidroside | Ischemic Stroke | 2 | PM | 34988203 | 📋 | Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB signaling pathway |
| Salidroside | Ischemic Stroke | 1 | PM | 33389472 | 📋 | Salidroside Inhibits Reactive Astrogliosis and Glial Scar Formation in Late Cerebral Ischemia via the Akt/GSK-3β Pathway |
| Salidroside | Ischemic Stroke | 6 | PM | 32603893 | 📋 | Salidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety |
| Salidroside | Ischemic Stroke | 5 | PM | 32518214 | 📋 | Fibroblast growth factor 2 contributes to the effect of salidroside on dendritic and synaptic plasticity after cerebral ischemia/reperfusion injury |
| Salidroside | Ischemic Stroke | 4 | PM | 26889188 | 📋 | Neuroprotective effects of salidroside on focal cerebral ischemia/reperfusion injury involve the nuclear erythroid 2-related factor 2 pathway |
| Salidroside | Middle Cerebral Artery Occlusion | 1 | PM | 35543160 | 📋 | Salidroside Ameliorates Ischemia-Induced Neuronal Injury through AMPK Dependent and Independent Pathways to Maintain Mitochondrial Quality Control |
| Salidroside | Middle Cerebral Artery Occlusion | 2 | PM | 31230155 | 📋 | Salidroside Reduces Inflammation and Brain Injury After Permanent Middle Cerebral Artery Occlusion in Rats by Regulating PI3K/PKB/Nrf2/NFκB Signaling Rather than Complement C3 Activity |
| Salidroside | Myocardial Fibrosis | 1 | PM | 37544102 | 📋 | Integrating network pharmacology and experimental verification to explore the mechanisms of salidroside against myocardial fibrosis |
| Salidroside | Myocardial Hypoxia | 4 | PM | 38737233 | 📋 | The application of proteomics and phosphoproteomics to reveal the molecular mechanism of salidroside in ameliorating myocardial hypoxia |
| Salidroside | Myocardial Hypoxia | 2 | PM | 32489291 | 📋 | Mechanism of salidroside relieving the acute hypoxia-induced myocardial injury through the PI3K/Akt pathway |
| Salidroside | Myocardial Hypoxia | 3 | PM | 31918273 | 📋 | Metabolic profiling reveals that salidroside antagonizes hypoxic injury via modulating energy and lipid metabolism in cardiomyocytes |
| Salidroside | Myocardial Hypoxia | 1 | PM | 30805019 | 📋 | Effects of Modulation of Ion Channel Currents by Salidroside in H9C2 Myocardial Cells in Hypoxia and Reoxygenation |
| Salidroside | Myocardial Infarction | 1 | PM | 31792327 | 📋 | Protective effects of Salidroside on cardiac function in mice with myocardial infarction |
| Salidroside | Myocardial Injury | 5 | PM | 31647492 | 📋 | Salidroside protects the cardiac function of exhausted rats by inducing Nrf2 expression |
| Salidroside | Myocardial Injury | 6 | PM | 31448659 | 📋 | Salidroside pretreatment protects against myocardial injury induced by heat stroke in mice |
| Salidroside | Myocardial Injury | 4 | PM | 28905500 | 📋 | Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo |
| Salidroside | Myocardial Injury | 3 | PM | 26167242 | 📋 | The Protective Effects of Salidroside from Exhaustive Exercise-Induced Heart Injury by Enhancing the PGC-1 α -NRF1/NRF2 Pathway and Mitochondrial Respiratory Function in Rats |
| Salidroside | Myocardial Injury | 2 | PM | 25682470 | 📋 | Effects of Salidroside on Myocardial Injury In Vivo In Vitro via Regulation of Nox/NF-κB/AP1 Pathway |
| Salidroside | Myocardial Injury | 1 | PM | 24454984 | 📋 | The protection of salidroside of the heart against acute exhaustive injury and molecular mechanism in rat |
| Salidroside | Myocardial Ischemia | 2 | PM | 31701727 | 📋 | [The effects of salidroside on the apoptosis pathway of myocardial cells in acute exhausted rats] |
| Salidroside | Myocardial Ischemia | 1 | PM | 21160132 | 📋 | Salidroside attenuates apoptosis in ischemic cardiomyocytes: a mechanism through a mitochondria-dependent pathway |
| Salidroside | Myocardial Ischemia-Reperfusion | 10 | PM | 38552436 | 📋 | Salidroside pretreatment alleviates ferroptosis induced by myocardial ischemia/reperfusion through mitochondrial superoxide-dependent AMPKα2 activation |
| Salidroside | Myocardial Ischemia-Reperfusion | 9 | PM | 37740139 | 📋 | Salidroside Ameliorates Ischemia/Reperfusion-Induced Human Cardiomyocyte Injury by Inhibiting the Circ_0097682/miR-671-5p/USP46 Pathway |
| Salidroside | Myocardial Ischemia-Reperfusion | 3 | PM | 35927086 | 📋 | Salidroside Inhibits Ischemia/Reperfusion-Induced Myocardial Apoptosis by Targeting Mir-378a-3p Via the Igf1r/Pi3k/Akt Signaling Pathway |
| Salidroside | Myocardial Ischemia-Reperfusion | 1 | PM | 35659894 | 📋 | Salidroside attenuates myocardial ischemia/reperfusion injury via AMPK-induced suppression of endoplasmic reticulum stress and mitochondrial fission |
| Salidroside | Myocardial Ischemia-Reperfusion | 2 | PM | 32858179 | 📋 | Salidroside inhibits apoptosis and autophagy of cardiomyocyte by regulation of circular RNA hsa_circ_0000064 in cardiac ischemia-reperfusion injury |
| Salidroside | Myocardial Ischemia-Reperfusion | 8 | PM | 32104217 | 📋 | MicroRNA-21 mediates the protective effects of salidroside against hypoxia/reoxygenation-induced myocardial oxidative stress and inflammatory response |
| Salidroside | Myocardial Ischemia-Reperfusion | 7 | PM | 27155549 | 📋 | Cardioprotective effects of salidroside on myocardial ischemia-reperfusion injury in coronary artery occlusion-induced rats and Langendorff-perfused rat hearts |
| Salidroside | Myocardial Ischemia-Reperfusion | 6 | PM | 26385354 | 📋 | The cardioprotective effect of salidroside against myocardial ischemia reperfusion injury in rats by inhibiting apoptosis and inflammation |
| Salidroside | Myocardial Ischemia-Reperfusion | 4 | PM | 23418859 | 📋 | Salidroside attenuates myocardial ischemia-reperfusion injury via PI3K/Akt signaling pathway |
| Salidroside | Myocardial Ischemia-Reperfusion | 5 | PM | 22771701 | 📋 | Salidroside and tyrosol from Rhodiola protect H9c2 cells from ischemia/reperfusion-induced apoptosis |
| Salidroside | Myocarditis | 1 | PM | 26104971 | 📋 | Salidroside Mitigates Sepsis-Induced Myocarditis in Rats by Regulating IGF-1/PI3K/Akt/GSK-3β Signaling |
| Salidroside | Peripheral Arterial Disease | 1 | PM | 28266625 | 📋 | Inhibition of PHD3 by salidroside promotes neovascularization through cell-cell communications mediated by muscle-secreted angiogenic factors |
| Salidroside | Platelet Aggregation | 1 | PM | 32352928 | 📋 | Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway |
| Salidroside | RBC Count High | 1 | PM | 33164438 | 📋 | [Proteomics analysis of erythrocyte membrane in rats with high altitude polycythemia before and after intervention with salidroside] |
| Salidroside | Renal Ischemia-Reperfusion | 1 | PM | 37822587 | 📋 | Salidroside inhibits renal ischemia/reperfusion injury‑induced ferroptosis by the PI3K/AKT signaling pathway |
| Salidroside | Right Ventricular Hypertrophy | 1 | PM | 25772255 | 📋 | Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway |
| Salidroside | Thrombosis | 1 | PM | 32352928 | 📋 | Salidroside inhibits platelet function and thrombus formation through AKT/GSK3β signaling pathway |
| Salidroside | Vascular Disorders | 2 | PM | 31656544 | 📋 | Salidroside prevents tumor necrosis factor-α-induced vascular inflammation by blocking mitogen-activated protein kinase and NF-κB signaling activation |
| Salidroside | Vasodilation | 1 | PM | 28803422 | 📋 | Salidroside improved cerebrovascular vasodilation in streptozotocin-induced diabetic rats through restoring the function of BKCa channel in smooth muscle cells |
